More on GILD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $157.37 |
|
|||
| Open | $157.32 | ||||
| 52 Wk High | $108.63 | ||||
| 52 Wk Low | $71.39 | ||||
| Day High | $157.58 | ||||
| Day Low | $155.62 | ||||
| P/E | 86.29 | ||||
| EPS | $1.81 | ||||
| Volume | 7,775,707 | ||||
- Form 4 GILEAD SCIENCES, INC. For: Oct 15 Filed by: Dickinson Andrew D
- Form 4 GILEAD SCIENCES, INC. For: Oct 15 Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Dickinson Andrew D
- Gilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Gilead Sciences (GILD) PT Raised to $164 at BofA Securities
- Gilead Sciences (GILD) PT Raised to $126 at RBC Capital
- Gilead Sciences (GILD) PT Raised to $170 at JPMorgan
- Gilead Sciences (GILD) PT Lowered to $163 at Morgan Stanley
- Gilead Sciences (GILD) PT Raised to $158 at Truist Securities
Entities mentioned with GILD
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Options | View Related Stories »
- Show More...
